AstraZeneca (AZN) call put ratio 1 call to 3.6 puts into shares selling off 15% on failed drug trial
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NYSE: AZN) call put ratio 1 call to 3.6 puts into shares selling off 15% on failed drug trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA grants accelerated approval to AstraZeneca's camizestrant combo
- TotalEnergies (TTE) call put ratio 10 calls 1 put with a focus on December calls as energy prices trend higher.
- Novartis (NVS) call put ratio 1.6 calls 1 put into share price lower before the bell
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
